The World Health Organization and partners allocated 70,000 doses of the Ervebo vaccine to the Democratic Republic of the Congo to combat its largest and fastest-spreading Ebola outbreak on record, which has confirmed over 5,000 cases and nearly 2,500 deaths across six eastern provinces.
While the country faces an escalating public health crisis caused by the Bundibugyo virus strain, international health authorities are deploying a vaccine typically reserved for Zaire strains. The intervention marks a major escalation in the global response to an epidemic that has outpaced previous outbreaks in speed and scale.
Emergency Allocation and Vaccine Strategy for Congo
Following an official request from the Congolese government, the International Coordinating Group on Vaccine Provision approved an immediate initial release of 70,000 doses of the rVSVΔG-ZEBOV-GP vaccine, widely known as Ervebo. The global vaccine alliance Gavi is providing $7 million to fund the shipment, alongside an additional $6 million dedicated to supporting vaccination efforts in high-risk areas.
The deployment is divided into two distinct operational strategies. According to the World Health Organization, 50,000 doses will be administered to frontline personnel and healthcare workers following recommendations from the Strategic Advisory Group of Experts on Immunization. The remaining 20,000 doses will be reserved for a late-stage Phase III clinical trial designed to evaluate the vaccine’s real-world impact against the specific viral strain driving the current emergency.
Addressing the Bundibugyo Virus Strain
A central scientific challenge facing responders is that Ervebo is officially licensed and recommended only for outbreaks of the Zaire ebolavirus strain. The current epidemic in eastern Congo is driven by the Bundibugyo species of Ebola, for which no specific vaccines or treatments have received regulatory approval.
“It is not known whether Ervebo may be protective against the Bundibugyo virus in humans, [but] early laboratory and animal data suggest it may provide some protection.”
World Health Organization
Because no established treatment exists for this rare strain, health officials emphasize that recipients participating in the trial and vaccination campaigns must receive comprehensive information regarding potential risks and limitations to ensure proper informed consent.
Unprecedented Scale of the Eastern Epidemic
The outbreak, which authorities suspect may have originated in the mining town of Mongbwalu as early as February before being officially declared on May 15, has surpassed previous historical markers. Government data confirms that confirmed cases have exceeded 5,000, with a death toll reaching 2,378 to 2,476 depending on reporting intervals. This surpasses the devastation of the 2018–2020 outbreak and spreads roughly three times faster than the 2014–2016 West African epidemic.
Fatality rates vary significantly across regions. While the overall average case fatality rate sits near 47.5%, the fatality rate climbs as high as 70% in more challenging operational environments like North Kivu province. United Nations officials note that ongoing transmission continues to outpace tracking efforts as many new cases emerge outside active monitoring circles.
Stepped-Up Humanitarian and Community Responses
United Nations representatives told reporters that humanitarian agencies are mounting a multi-layered defense. Julian Harneis, the senior Ebola coordinator on the ground, outlined five operational priorities for the response: tripling safe care capacity, strengthening community engagement, doubling safe and dignified burial teams, expanding disease surveillance, and increasing support for vulnerable populations.
In parallel, the Congolese government has launched the Congo River Without Ebola
initiative with UN backing to tighten disease surveillance and regional preparedness. These measures align with the broader framework supported by the Africa Centres for Disease Control and Prevention, which emphasizes community-led approaches to keep affected populations at the center of containment efforts.
